Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Total Current Liabilities (2010 - 2026)

Nomad Power Solutions (NMAD) posted Total Current Liabilities of $1.5 million for Q2 2026, up 12.52% on a QoQ basis from $1.3 million in Q4 2025, and up 179.27% year-over-year from $537122.0 in Q2 2025.

Analysis

Nomad Power Solutions (NMAD) Total Current Liabilities (2010 - 2026) Analysis & Trends

Nomad Power Solutions has reported Total Current Liabilities for 17 years, with the latest figure at $1.5 million in Q2 2026.

  • On a quarterly basis, Total Current Liabilities rose 179.27% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 179.27% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 318.84% from the prior year.
  • Total Current Liabilities was $1.5 million for Q2 2026 at Nomad Power Solutions, up from $1.3 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $1.5 million in Q2 2026, with the low at $249987.0 in Q1 2023.
  • Average Total Current Liabilities over 5 years is $531571.4, with a median of $408328.0 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Total Current Liabilities sank 61.22% in 2023, then jumped 318.84% in 2025.
  • Over 5 years, Total Current Liabilities stood at $395756.0 in 2022, then declined by 20.69% to $313858.0 in 2023, then grew by 1.41% to $318284.0 in 2024, then surged by 318.84% to $1.3 million in 2025, then increased by 12.52% to $1.5 million in 2026.
  • The last three Total Current Liabilities figures came in at $1.5 million (Q2 2026), $1.3 million (Q4 2025), and $521422.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.58 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 283.60 Mn
10 Nomad Power Solutions 49.59 Mn 49.59 Mn - 1.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.50 Mn
Dec 31, 2025 1.33 Mn
Sep 30, 2025 521,422.00
Jun 30, 2025 537,122.00
Mar 31, 2025 355,098.00
Dec 31, 2024 318,284.00
Sep 30, 2024 328,956.00
Jun 30, 2024 421,465.00
Mar 31, 2024 462,836.00
Dec 31, 2023 313,858.00
Sep 30, 2023 311,736.00
Jun 30, 2023 402,614.00
Mar 31, 2023 249,987.00
Dec 31, 2022 395,756.00
Sep 30, 2022 408,328.00
Jun 30, 2022 531,540.00
Mar 31, 2022 644,593.00
Dec 31, 2021 302,926.00
Sep 30, 2021 258,699.00
Jun 30, 2021 376,326.00